Study details
Enrolling now
Neuromodulation and Cognitive Training in Opioid Use Disorder
University of Minnesota
NCT IDNCT03773523ClinicalTrials.gov data as of Apr 2026
Target enrollment
30
Study length
about 6.8 years
Ages
18–60
Locations
1 site in MN
About this study
This trial is testing if neuromodulation, specifically transcranial direct current stimulation (tDCS), can help people with opioid use disorder. The goal is to improve treatment outcomes by targeting brain changes that lead to relapse.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Transcranial Direct Current Stimulation (tDCS)
Primary goalChange in brain functional connectivity as measured by functional magnetic resonance imaging
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low10%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Change in brain functional connectivity as measured by functional magnetic resonance imaging
Devices
therapeutic
Body systems
Psychiatry / Mental Health